Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy

PHASE3RecruitingINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

December 27, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2030

Conditions
Bietti Crystalline Corneoretinal DystrophyBietti Crystalline Dystrophy
Interventions
DRUG

ZVS101e

subretinal injection of ZVS101e

Trial Locations (8)

Unknown

NOT_YET_RECRUITING

Peking University Third Hospital, Beijing

NOT_YET_RECRUITING

Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou

NOT_YET_RECRUITING

The First Affiliated Hospital of Harbin Medical University, Haerbin

NOT_YET_RECRUITING

Henan Provincial People's Hospital, Zhengzhou

NOT_YET_RECRUITING

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai

NOT_YET_RECRUITING

West China Hospital of Sichuan University, Chengdu

RECRUITING

Tianjin Medical University Eye Hospital, Tianjin

NOT_YET_RECRUITING

Eye Hospital, Wenzhou Medical University, Wenzhou

All Listed Sponsors
lead

Chigenovo Co., Ltd

NETWORK